Kalaris Therapeutics, Inc. - KLRS

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
03/20/2026	03/23/2026	Hagen Brett R Chief Accounting Officer Officer	Sell	-1,915 @ $6.72	($12,868.80)	0	(-100.00%)	Direct